Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4	3	12	7	18	25
Market Cap Growth	-62.96%	-75.72%	66.86%	-62.07%	-27.98%	37.89%
Enterprise Value	6	4	9	4	16	20
Last Close Price	0.06	0.04	0.16	0.09	0.25	0.34
PE Ratio	-	-	-	70.85	-	-
Forward PE	-	1.95	1.95	1.95	1.95	1.95
PS Ratio	-	-	445.57	-	704.04	36.26
PB Ratio	0.11	0.07	0.26	0.15	0.40	0.54
P/TBV Ratio	-	-	3.85	1.98	5.37	5.22
P/OCF Ratio	-	-	10.33	5.32	-	-
EV/Sales Ratio	-	-	347.23	-	597.27	27.83
Net Debt / Equity Ratio	-1.01	-1.01	-1.03	-1.02	-1.02	-1.01
Asset Turnover	-	-	0.00	-	0.00	0.02
Quick Ratio	58.24	58.24	27.93	27.43	27.65	118.29
Current Ratio	58.57	58.57	28.10	27.62	27.89	118.50
Return on Equity (ROE)	-7.79%	-7.79%	1.70%	2.99%	-0.40%	-0.99%
Return on Assets (ROA)	-1.88%	-1.88%	-1.75%	-1.37%	-1.35%	-0.61%
Return on Capital Employed (ROCE)	-3.20%	-3.20%	-2.90%	-2.30%	-2.20%	-1.00%
Earnings Yield	-124.26%	-121.20%	6.72%	19.78%	-1.02%	-1.85%
Payout Ratio	-	-	163.88%	92.86%	-	-
Buyback Yield / Dilution	-	-	-	-	-	-45.23%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.